← Back to Clinical Trials
Recruiting NCT07171151

NCT07171151 Detection of Disease Marker Factors in Cyst Fluid

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07171151
Status Recruiting
Phase
Sponsor Harran University
Condition Biomarkers
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2025-08-25
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
cyst fluid examination

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 25 participants in total. It began in 2025-08-25 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this observational study is to examine the cyst fluid obtained after a puncture procedure performed for cyst diagnosis in participants with cystic lesions on clinical and radiological examination.The main question it aims to answer is: \- What is the exact mechanism of formation of odontogenic cysts? Biomarkers in the cyst fluid obtained after a puncture procedure performed as part of the diagnosis and treatment process of odontogenic cysts will be examined. The aim of this study is to gain insight into cyst pathology by examining the levels of biomarkers in odontogenic cyst fluid.

Eligibility Criteria

Inclusion Criteria: 1. Individuals diagnosed with cysts 2. Individuals who are not pregnant or breastfeeding 3. Individuals who agree to sign the informed consent form Exclusion Criteria: 1. Systemically ill individuals who are contraindicated for surgery. 2. Individuals who do not wish to sign the informed consent form. 3. Individuals who are pregnant, breastfeeding, or using oral contraceptives will be excluded.

Contact & Investigator

Central Contact

mine alkaya karagoz

✉ minekaragoz@harran.edu.tr

📞 905365417606

Principal Investigator

hande has elci

PRINCIPAL INVESTIGATOR

Harran University

Frequently Asked Questions

Who can join the NCT07171151 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 80 Years, studying Biomarkers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07171151 currently recruiting?

Yes, NCT07171151 is actively recruiting participants. Contact the research team at minekaragoz@harran.edu.tr for enrollment information.

Where is the NCT07171151 trial being conducted?

This trial is being conducted at Sanliurfa, Turkey (Türkiye).

Who is sponsoring the NCT07171151 clinical trial?

NCT07171151 is sponsored by Harran University. The principal investigator is hande has elci at Harran University. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology